首页>投融资
HistoSonics
D轮
HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others
基本信息
-
公司全称Histosonics Inc
-
类型机器人辅助声波疗法研发商
-
产业领域器械/设备、消费
-
公司人数15~50人
-
地址3626 West Liberty Road Suite 100 ANN ARBOR MICHIGAN 48103; US; Telephone: +17349264633;
-
联系电话17349264633
-
邮箱info@histosonics.com
-
成立时间2009-01-01
投融资
-
2024-08-15D轮1.02亿美元Alpha WaveAmzak Health InvestorsHealthQuest CapitalJohnson & Johnson InnovationVenture InvestorsLumira VenturesYonjin VentureSWIB
-
2022-12-13未公开8500万美元Venture InvestorsJohnson & Johnson InnovationYonjin VentureLumira VenturesSWIB
-
2022-12-13或有债权1500万美元未透露
-
2020-06-08C+轮4000万美元Venture InvestorsJohnson & Johnson InnovationVarian Medical SystemsYonjin VentureLumira VenturesSWIB
-
2020-01-13未公开8700万美元未透露
-
2019-04-08C轮5400万美元Johnson & Johnson InnovationVarian Medical SystemsLumira Ventures
-
2018-07-13未公开500万美元未透露
-
2017-03-13B轮未透露Venture InvestorsTGap VenturesGrand AngelsEarly Stage PartnersUM-MINTSHatteras Venture PartnersWolverine Venture FundFletcher Spaght
-
2015-09-03未公开300万美元Hatteras Venture PartnersTGap VenturesFletcher SpaghtEarly Stage Partners
-
2010-04-20A轮1100万美元Venture InvestorsEarly Stage PartnersHatteras Venture PartnersTGap VenturesFletcher Spaght
- 加载更多
相关投融资企业
D轮
HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others
未公开
Kestra Medical Technologies是一家用于医疗保健行业的外部和内部心脏医疗设备的制造商。该公司的可穿戴式心律转复除颤器与设备疗法结合了技术方面,提供护理和重要信息,帮助患者及其护理团队和谐地监测、管理和保护生命。